“We are very pleased to be invited by Dr Nagourney to assist in this patient’s treatment.
The patient’s tumour type (renal cell carcinoma) fits in with the results we saw in the
Australian Phase I trials where we saw a patient with end stage RCC respond to the
Coramsine® therapy. That patient remains in remission to this day.” David Sparling,
Solbec’s General Manager
- Forums
- ASX - By Stock
- SBP
- cure for cancer.........
SBP
solbec pharmaceuticals limited
cure for cancer.........
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.